BRISTOL-MYERS SQUIBB COMPANY

Trading Ideas Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Market Closed - Nyse Other stock markets 16:00:02 2024-05-08 EDT			5-day change	1st Jan Change
43.67 ^USD	-0.84%		-1.22%	-14.89%

05-07	Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates	MT
05-06	Top Midday Stories: Tyson Shares Tumble on Earnings Miss; Robinhood Receives Wells Notice From SEC Staff; Spirit Airlines to Furlough up to 260 Pilots; Shell in Talks to Sell Malaysian Gas Station Business to Saudi Aramco	MT

Trading Ideas

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BRISTOL-MYERS SQUIBB COMPANY :The beginning of the move	19-09-18
BRISTOL-MYERS SQUIBB COMPANY :Underpinned by a support level	19-04-08
BRISTOL-MYERS SQUIBB COMPANY :Attractive price levels	16-09-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 01:06 pm

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW